Skip to content

David Cunningham

Royal Marsden Hospital

3 papers in the Anchorcite directory, published between 2004 and 2010, cited 15,984 times in total.

ORCID profile

Research topics

Frequent co-authors

  • Timothy J. Iveson · 2 papers
  • William Allum · 1 paper
  • Sally Patricia Stenning · 1 paper
  • Jeremy N. Thompson · 1 paper
  • Cornelis J.�H. van de Velde · 1 paper
  • Marianne C. Nicolson · 1 paper
  • J. Howard Scarffe · 1 paper
  • Fiona J. Lofts · 1 paper

Papers

  1. Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal CancerNew England Journal of Medicine · 2006 · 6,411 citations

    BACKGROUND: A regimen of epirubicin, cisplatin, and infused fluorouracil (ECF) improves survival among patients with incurable locally advanced or metastatic gastric adenocarcinoma. We assessed whether the addition of a perioperative regimen of ECF to surgery improves outcomes among patients with…

  2. Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal CancerNew England Journal of Medicine · 2004 · 5,069 citations

    BACKGROUND: The epidermal growth factor receptor (EGFR), which participates in signaling pathways that are deregulated in cancer cells, commonly appears on colorectal-cancer cells. Cetuximab is a monoclonal antibody that specifically blocks the EGFR. We compared the efficacy of cetuximab in…

  3. Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract CancerNew England Journal of Medicine · 2010 · 4,504 citations

    BACKGROUND: There is no established standard chemotherapy for patients with locally advanced or metastatic biliary tract cancer. We initially conducted a randomized, phase 2 study involving 86 patients to compare cisplatin plus gemcitabine with gemcitabine alone. After we found an…

Metadata from OpenAlex (CC0).